Mode Sensors
About[edit]
Mode Sensors AS is a Norwegian medical technology company developing wearable monitoring solutions for fluid management in clinical settings. Founded in 2016 with 10 employees.
Product[edit]
Re:Balans[edit]
Re:Balans is an FDA-cleared medical-grade wearable device for non-invasive, real-time fluid monitoring. Key features:
- Non-invasive measurement of fluid status
- Real-time monitoring capability
- Medical-grade accuracy
- US market clearance (FDA)
Clinical Need[edit]
Fluid overload (hypervolemia) and dehydration (hypovolemia) are common clinical challenges in:
- Heart failure patients
- Kidney disease patients
- Post-operative patients
- General hospital ward monitoring
Current methods for assessing fluid status (weight, physical exam, invasive central venous pressure) are imprecise or risky. A non-invasive wearable that continuously monitors fluid status addresses a significant clinical gap.
Market Position[edit]
FDA clearance is a significant achievement and regulatory milestone. The US market focus indicates commercial ambition beyond Norway. Heart failure affects approximately 64 million people globally, representing a large addressable market.